The ALG14 gene helps your cells attach small sugar chains to proteins, an essential step that supports how nerves, muscles, and many other tissues work. If this gene does not work properly, some proteins are not processed as they should, which can lead to muscle weakness that often gets worse with activity, and sometimes low muscle tone, developmental delay, or seizures. Doctors link harmful variants in the ALG14 gene to rare inherited conditions, including some forms of congenital myasthenic syndrome and conditions affecting protein glycosylation (the way cells add sugars to proteins).
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or to manage processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do the work. Others mainly help set when certain processes happen, where they happen, and how strongly they occur. As a group, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To look into this topic more deeply, you can learn more in the LearnHub.
Overview
ALG14Gene function
What if the gene works
The ALG14 gene helps cells build sugar chains that are attached to many proteins. This protein tagging step supports normal protein folding, stability, and function.
Risk
What if the gene does not work
Pathogenic variants in the ALG14 gene can cause a congenital myasthenic condition with muscle weakness and easy tiring, ranging from mild to more marked. Some variants also disrupt sugar tagging of proteins, sometimes leading to broader developmental problems.
Treatment
What does that mean for your treatment
No ALG14-specific treatment or management approach is currently established in clinical guidelines. In reported ALG14-related congenital myasthenic syndrome, clinicians may use standard congenital myasthenic syndrome medicines such as pyridostigmine, but treatment choice is guided by the person’s symptoms and response rather than by an ALG14-specific drug rule.
Conditions associated with ALG14
Gene function
What if the gene works
Inside your cells, the ALG14 gene helps build the sugar starter used for adding sugar chains to proteins. This early step happens in the endoplasmic reticulum (the part of the cell that processes many proteins). Normal ALG14 activity supports smooth protein handling across many tissues.
The ALG14 gene helps build the starter structure used in N-linked glycosylation (adding sugar chains to proteins). Its protein helps place an early sugar piece in the right order.
Many newly made proteins need these sugar chains before they can fold, travel, and work as expected. By supporting this early step, ALG14 helps routine protein processing in many parts of the body.
The ALG14 protein sits at the endoplasmic reticulum membrane and works with partner proteins there. This setup keeps the sugar building step close to where many proteins are being prepared.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. Variants are common and are one reason people differ from one another in normal ways, such as appearance, metabolism, or how the body responds to environmental influences. Many do not produce any noticeable effect and simply represent natural genetic variation. At times, however, a variant can change gene function more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ALG14 gene can change the shape, stability, or amount of the ALG14 protein, so cells may not add sugar chains to proteins properly. Some ALG14 gene variants linked to congenital myasthenic syndrome only partly reduce this step, while more disruptive changes, including some splice or truncating variants, can sharply lower protein function or stop partner binding. This range in effect helps explain why some people have milder, later symptoms, while others develop earlier or broader features.
How variants are linked to conditions
Pathogenic variants in the ALG14 gene cause congenital myasthenic syndrome 15, a rare inherited condition marked by muscle weakness that often starts in infancy or childhood and may worsen with activity. In some people, variants in the ALG14 gene linked to congenital myasthenic syndrome are also associated with low muscle tone, delayed motor milestones, and tubular aggregates seen on muscle biopsy. Because this is a monogenic condition, finding pathogenic variants in both gene copies can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common and are a usual part of human biology. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALG14-related conditions, risk is mainly shaped by whether a disease-causing change in the ALG14 gene is inherited, so family history and whether both parents carry a harmful variant matter most. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change the chance of developing an ALG14-related condition.
Inheritance of ALG14 variants
Variants in the ALG14 gene linked to known ALG14-related conditions are inherited in an autosomal recessive pattern. This ALG14 inheritance pattern means a person usually inherits one changed copy from each parent, and the parents are often healthy carriers. When both parents carry an ALG14 gene variant, each child has a 25% chance of inheriting both changed copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither changed copy. This chance is the same for sons and daughters.
What does my ALG14 result mean for my family?
For the recognized ALG14-related condition, family members are usually affected only when they inherit a changed copy of the gene from each parent. That means parents are often healthy carriers, and brothers and sisters may also be carriers or, less often, have the condition. Other relatives on both sides of the family could carry the same gene change.
Genetic information
Genetic testing
How you find out about variants
Variants in the ALG14 gene are usually found with genetic testing for ALG14 variants, using a blood sample, saliva, or a cheek swab. A lab reads the gene's DNA code and compares it with the usual sequence to look for changes. Results may show a variant linked to disease, a harmless variant, or a finding whose meaning is still unclear.
When should I consider getting a genetic test?
Genetic testing for the ALG14 gene may be considered when someone has unexplained muscle weakness that worsens with activity, especially from infancy or childhood, or when a related inherited condition runs in the family. It can help confirm an inherited condition that affects how nerves signal muscles.
A genetic result is only one part of your health story
How informative a genetic result is depends on both the condition and the type of variant involved, although it can provide meaningful insight. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered together with other aspects of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people taking the same treatment may process it differently because their bodies break down, move, or respond to the drug in different ways. This is common and can influence how well a medicine works or how likely someone is to have side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences affect the way people respond to medications. It examines links between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes help shape how strongly a drug works or how the body processes it. This information can support treatment choices that are more informed and more individualized. To look into this subject more closely, you can learn more in the LearnHub.
Drugs influenced by the ALG14 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects may happen. General questions about symptoms, new side effects, or medication changes are best discussed with your doctor.